论文部分内容阅读
Chemotherapy-related cognitive impairment (CRCI), and neurotransmitter signaling, longevity, and inf
【作 者】
：
【机 构】
：
Department of Surgery, University of Rochester Medical Center, Rochester, NY
【出 处】
：
2015年临床肿瘤学新进展学术研讨会
【发表日期】
：
2015年3期
其他文献
Phase Ⅲ, randomized, double-blind, multicenter, placebo (P)-controlled trial of rilotumumab (R) plus
会议
Relationship between PD-L1 expression and clinical outcomes in patients with advanced gastric cancer
会议
会议
Interest of short hormonotherapy (HT) associated with radiotherapy (RT) as salvage treatment for bio
会议
First-line randomized phase Ⅱ study of gemcitabine/cisplatin plus apatorsen or placebo in patients w
会议
TROG 03.06 and VCOG PR 01-03: The “timing of androgen deprivation therapy in prostate cancer patient
会议
A phase Ⅱ/Ⅲ, double-blind, randomized trial comparing maintenance lapatinib versus placebo after fir
会议